Research Paper Volume 11, Issue 16 pp 6237—6251

Prognostic value of long non-coding RNA signatures in bladder cancer

Figure 3. (A, C and E) Overall survival curves of BLCA patients in training, validation and all cohorts with a low or high risk of death, according to 14-lncRNA-based classifier risk score level. (B, D and F): Relapse-free survival curves of BLCA patients in training, validation and all cohorts with a low or high risk of death, according to 12-lncRNA-based classifier risk score level.